Anika to present regenerative medicine and orthobiologics developments

Written by Alan Condon | May 13, 2019 | Print  |

Bedford, Mass.-based biotechnology company Anika Therapeutics will feature its orthobiologics and regenerative medicine lineup at the 12th Biennial International Society of Arthroscopy, Knee Surgery and Orthopaedic Sports Medicine Congress in Mexico.

The event, which Anika is a gold sponsor of, began May 12 and runs through May 16.

Three things to know:

1. Anika is set to feature a lecture session on HYALOFAST for the repair of chondral or osteochondral lesions, and CINGAL, which is a combination of hyaluronic acid and steroid treatment to combat osteoarthritis.

2. The company will also feature its injectable, hyaluronic acid-based, surgical bone repair therapy and conduct demonstrations of HYALOFAST procedures with the arthroscopic virtual surgery simulator.

3. The ISAKOS Congress highlights a variety of new preventative, therapeutic and surgical technique information, featuring surgical demonstrations, paper presentations, debates, lectures, symposia and instructional course lectures.

4. "Orthopedic sports medicine and sports-related injuries are a key focus for us given our extensive treatment portfolio that spans the continuum of orthopedic care," said Joseph Darling, president and CEO of Anika Therapeutics.

More articles on devices:
Joimax presents new spine device at Global Spine Congress
Portable 3D ultrasound imaging device developed for scoliosis
Why Alphatec Spine is focused on titanium, not 3D printing going forward

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months